# Psychedelic drugmakers may gain momentum from HHS-VA agreement US government collaboration expands for psychedelic medicine research - **Source:** [Breaking News on Seeking Alpha](https://brifing.si/source/9a596115-e1cc-45e7-b5ba-070be9ea2998) - **Published:** 2026-07-13 - **Topic:** [Business](https://brifing.si/c/business) - **Original article:** - **On Brifing:** https://brifing.si/s/6c4e1ebc-e3e2-4524-a84c-bcff750c55bc ## Intergovernmental cooperation The memorandum of understanding signed between HHS and VA provides significant support for psychedelic drug research. This agreement creates opportunities for companies developing treatments for veterans' mental health issues. ## Rise of psychedelic therapies In recent years, the therapeutic potential of substances like psilocybin and MDMA has gained increasing recognition. This development opens doors for biotech companies offering groundbreaking mental health treatments. ## Special focus on veterans VA's involvement indicates particular focus on treating post-traumatic stress disorder (PTSD) among veterans. Military personnel's mental health has long been a priority health issue in the US. ## Investor opportunities This government support could boost investments in psychedelic drug developers. Sector analysts note that biotech firms in clinical trial phases may particularly benefit from this development. ## Regulatory hurdles Therapeutic use of psychedelic substances still faces many regulatory barriers. However, such government collaborations may help overcome these obstacles and increase the sector's legitimacy. ## Revolution in mental health This development could bring new hope for mental health conditions unresponsive to traditional treatments. Advances in psychedelic research have potential to transform the entire healthcare sector. ## Sources covering this story - https://seekingalpha.com/news/4613407-psychedelic-drugmakers-could-get-boost-hhs-va-memorandum?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._